The Discounted Cash Flow (DCF) valuation of Aurinia Pharmaceuticals Inc (AUP.TO) is (83.32) CAD. With the latest stock price at 16.76 CAD, the upside of Aurinia Pharmaceuticals Inc based on DCF is -597.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 5.6% | 5.3% |
| Long-term Growth Rate | 3.0% - 4.7% | 3.9% |
| Fair Price | (472.82) - (46.43) | (83.32) |
| Upside | -2921.1% - -377.0% | -597.1% |